|
End-of-day quote
Taiwan S.E.
2026-11-13
|
5-day change | 1st Jan Change | ||
| 1,380.00 TWD | +1.10% |
|
+8.66% | +225.70% |
| Nov. 13 | PharmaEssentia Wins Mexico Approval for BESREMi to Treat Polycythemia Vera | MT |
| Nov. 09 | PharmaEssentia Gets Board Nod for NT$675 Million Investment in Life Sciences Fund; Shares Down 4% | MT |
| Market Cap | 572B 17.38B 15.75B 14.56B 13.14B 24.76B 1,638B 25.64B 175B 69.37B 875B 65.21B 63.82B 2,778B | P/E 2026 * |
53.4x | P/E 2027 * | 32.4x |
|---|---|---|---|---|---|
| Enterprise Value | 549B 16.68B 15.11B 13.98B 12.61B 23.77B 1,572B 24.6B 168B 66.58B 840B 62.58B 61.25B 2,666B | EV / Sales 2026 * |
19.6x | EV / Sales 2027 * | 12.5x |
| Free-Float |
79.22% | Yield 2026 * |
0.29% | Yield 2027 * | 0.17% |
| 1 day | +1.10% | ||
| 1 week | +8.66% | ||
| Current month | +15.97% | ||
| 1 month | +18.45% | ||
| 3 months | -4.50% | ||
| 6 months | +95.75% | ||
| Current year | +225.70% |
| 1 week | 1,235 |  | 1,410 |
| 1 month | 1,075 | | 1,410 |
| Current year | 423.7 | | 1,645 |
| 1 year | 407.92 | | 1,645 |
| 3 years | 228.27 | | 1,645 |
| 5 years | 96.26 | | 1,645 |
| 10 years | 43.54 | | 1,645 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 2016-12-31 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 2015-10-13 |
Cheng Ku Huang
PSD | President | - | 2015-06-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
BRD | Director/Board Member | - | 2000-05-08 |
Ching-Leou Teng
CHM | Chairman | - | 2012-09-23 |
Cheng Ku Huang
BRD | Director/Board Member | - | 2015-05-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.10% | +8.66% | +210.51% | +390.98% | 17.38B | |
| -2.69% | -0.48% | +51.67% | +69.09% | 66.33B | |
| -0.92% | +7.67% | +14.26% | +90.92% | 60.62B | |
| 0.00% | +0.39% | +20.52% | +98.45% | 55.5B | |
| +0.14% | +2.35% | +13.08% | +109.47% | 47.58B | |
| -2.21% | -2.47% | +18.60% | +36.89% | 43.69B | |
| -2.30% | -10.40% | +167.61% | +776.79% | 37.27B | |
| +2.15% | +1.42% | +15.17% | +56.49% | 36.57B | |
| -2.32% | -2.24% | +75.52% | +52.70% | 32.22B | |
| +2.62% | +5.90% | -36.55% | +406.95% | 26.58B | |
| Average | -0.44% | +0.12% | +55.04% | +208.87% | 42B | |
| Weighted average by Cap. | -0.75% | +0.22% | +44.33% | +171.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 28.05B 852M 772M 714M 644M 1.21B 80.34B 1.26B 8.58B 3.4B 42.92B 3.2B 3.13B 136B | 42.9B 1.3B 1.18B 1.09B 986M 1.86B 123B 1.92B 13.12B 5.2B 65.64B 4.89B 4.79B 208B |
| Net income | 10.78B 327M 297M 274M 248M 467M 30.87B 483M 3.3B 1.31B 16.49B 1.23B 1.2B 52.34B | 17.87B 543M 492M 455M 411M 774M 51.19B 801M 5.47B 2.17B 27.35B 2.04B 1.99B 86.8B |
| Net Debt | -23.05B -700M -635M -587M -530M -998M -66.03B -1.03B -7.05B -2.8B -35.27B -2.63B -2.57B -112B | -34.24B -1.04B -943M -872M -787M -1.48B -98.09B -1.53B -10.48B -4.15B -52.4B -3.9B -3.82B -166B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | NT$1,380.00 | +1.10% | 3,704,927 |
| 26-11-12 | NT$1,365.00 | +2.25% | 5,539,266 |
| 26-11-11 | NT$1,335.00 | +4.30% | 3,437,041 |
| 26-11-10 | NT$1,280.00 | -6.57% | 6,950,030 |
| 26-11-09 | NT$1,370.00 | +7.87% | 5,627,041 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- 6446 Stock
Select your edition
All financial news and data tailored to specific country editions
